Ivermectin – Antiparasitic Therapy
Ivermectin is a semi-synthetic antiparasitic agent derived from avermectins, produced by the soil bacterium Streptomyces avermitilis. It is a broad-spectrum drug highly effective against various endo- and ectoparasites.
The mechanism of action involves selective binding to glutamate-gated chloride channels found in the nerve and muscle cells of invertebrates. This increases the permeability of the cell membrane to chloride ions, causing cell hyperpolarization, paralysis, and the eventual death of the parasite. In mammals, ivermectin has a very low affinity for similar channels and does not cross the blood-brain barrier at therapeutic doses, ensuring high safety for humans.
The medication is administered orally (tablets) or topically (creams and lotions) depending on the nature of the infection.
Indications
Ivermectin is indicated for the treatment of adults and children (weighing more than 15 kg) in the following conditions:
- Strongyloidiasis: intestinal infection caused by Strongyloides stercoralis.
- Onchocerciasis: also known as "river blindness," caused by Onchocerca volvulus.
- Scabies: treatment of resistant or crusted (Norwegian) scabies, often in combination with topical agents.
- Rosacea: topical treatment of papulopustular lesions in adult patients.
- Other Helminthiases: may be used for ascariasis, filariasis, and pediculosis (head lice).
Dosage and administration
The dosage of ivermectin is calculated based on the patient's body weight and the specific type of infection.
- Standard Oral Dose: typically a single dose of 200 mcg per kg of body weight.
- Scabies Protocol: a single dose of 200 mcg/kg, which may be repeated after 8–15 days if necessary.
- Administration: tablets should be taken with water on an empty stomach (1 hour before or 2 hours after a meal).
- Topical Use: cream should be applied once daily in a thin layer to the affected facial areas.